These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 679621)

  • 1. Internal mammary lymphoscintigraphy: a rational adjunct to the staging and management of breast carcinoma.
    Ege GN
    Clin Radiol; 1978 Jul; 29(4):453-6. PubMed ID: 679621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoscintigraphy--techniques and applications in the management of breast carcinoma.
    Ege GN
    Semin Nucl Med; 1983 Jan; 13(1):26-34. PubMed ID: 6836316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoscintigraphy in staging and management of breast cancer.
    Nisa L; Hussain F; Yasmin S; Afroj K
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):8-14. PubMed ID: 11192493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
    McLean RG; Ege GN
    J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internal mammary lymphoscintigraphy in the conservative management of breast carcinoma: an update and recommendations for a new TNM staging.
    Ege GN; Clark RM
    Clin Radiol; 1985 Sep; 36(5):469-72. PubMed ID: 4075713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiocolloid lymphoscintigraphy in neoplastic disease.
    Ege GN
    Cancer Res; 1980 Aug; 40(8 Pt 2):3065-71. PubMed ID: 7397701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal mammary lymphoscintigraphy.
    Staples D; Daniels C
    Radiol Technol; 1999; 70(4):385-6. PubMed ID: 10101754
    [No Abstract]   [Full Text] [Related]  

  • 9. Internal mammary lymphoscintigraphy: current status in the treatment of breast cancer.
    Bourgeois P; Frühling JG
    Crit Rev Oncol Hematol; 1983; 1(1):21-47. PubMed ID: 6394167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
    Serin D; Vinot JM; Martin P; Reboul F; Robin M; Chevallier J
    Bull Cancer; 1986; 73(3):299-304. PubMed ID: 3756366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of axillary metastases in breast cancer by lymphoscintigraphy.
    Black RB; Merrick MV; Taylor TV; Forrest AP
    Lancet; 1980 Jul; 2(8184):15-7. PubMed ID: 6104225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary lymphoscintigraphy in breast cancer.
    Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
    J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative lymphoscintigraphy be used as a guide in treatment planning of breast cancer?
    Mudun A; Aslay I; Aygen M; Muslumanoglu M; Bozfakioglu Y; Cantez S
    Clin Nucl Med; 2001 May; 26(5):405-11. PubMed ID: 11317020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of internal mammary lymphoscintigraphy in the clinical staging and prognosis of patients with breast cancer.
    Casara D
    Tumori; 1997; 83(2):526-9. PubMed ID: 9226010
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation dose estimates for interstitial radiocolloid lymphoscintigraphy.
    Bronskill MJ
    Semin Nucl Med; 1983 Jan; 13(1):20-5. PubMed ID: 6836315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of internal mammary lymphoscintigraphy in the management of breast carcinoma.
    Ege GN; Elhakim T
    J Clin Oncol; 1984 Jul; 2(7):774-81. PubMed ID: 6737019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.